Palbociclib-The First of a New Class of Cell Cycle Inhibitors

Marcus Schmidt1, Martin Sebastian2

  • 1Department of Obstetrics and Gynecology, University Medical Center Mainz, Langenbeckstr. 1, 55131, Mainz, Germany. marcus.schmidt@unimedizin-mainz.de.

Insights

Palbociclib, a cyclin-dependent kinase (CDK) 4/6 inhibitor, significantly improves progression-free survival in advanced ER-positive/HER2-negative breast cancer when combined with endocrine therapy. This treatment is well-tolerated, with manageable side effects like neutropenia.

Area of Science:

  • Oncology
  • Pharmacology
  • Cell Biology

Background:

  • Cyclin-dependent kinases (CDKs) regulate cell cycle progression, with CDK4/6 being crucial for the G1-S phase transition.
  • Dysregulation of cell cycle control is a hallmark of cancer, making CDK inhibitors a target for cancer therapy.

Purpose of the Study:

  • To evaluate the efficacy and safety of palbociclib, an oral CDK4/6 inhibitor, in combination with endocrine therapy for advanced ER-positive/HER2-negative breast cancer.
  • To assess the impact of palbociclib on progression-free survival (PFS) and overall quality of life (QoL).

Main Methods:

  • Clinical trials (PALOMA-2 and PALOMA-3) involving patients with advanced ER-positive/HER2-negative breast cancer.
  • Palbociclib administered orally in combination with letrozole (first-line) or fulvestrant (endocrine pretreated).

Main Results:

  • Palbociclib significantly prolonged PFS compared to placebo in both first-line (24.8 vs. 14.5 months) and endocrine-pretreated (9.2 vs. 3.8 months) settings.
  • The primary toxicity observed was neutropenia, which was manageable through dose adjustments, leading to a favorable safety profile and delayed QoL deterioration.

Conclusions:

  • Palbociclib in combination with endocrine therapy is an effective and well-tolerated treatment for advanced ER-positive/HER2-negative breast cancer.
  • Further research is ongoing to explore palbociclib's role in early-stage breast cancer and other cancer types, with a need for predictive biomarkers.

Related Concept Videos

What is the Cell Cycle?00:56

What is the Cell Cycle?

The cell cycle refers to the sequence of events occurring throughout a typical cell’s life. In eukaryotic cells, the somatic cell cycle has two stages: the interphase and the mitotic phase. During interphase, the cell grows, performs its basic metabolic functions, copies its DNA, and prepares for mitotic cell division. Then, during mitosis and cytokinesis, the cell divides its nuclear and cytoplasmic materials, respectively. This generates two daughter cells that are identical to the...
10.6K
What is the Cell Cycle?01:04

What is the Cell Cycle?

The cell cycle refers to the sequence of events occurring throughout a typical cell’s life. In eukaryotic cells, the somatic cell cycle has two stages: interphase and the mitotic phase. During interphase, the cell grows, performs its basic metabolic functions, copies its DNA, and prepares for mitotic cell division. Then, during mitosis and cytokinesis, the cell divides its nuclear and cytoplasmic materials, respectively. This generates two daughter cells that are identical to the original...
243.3K
Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
78.1K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K
The Cell Cycle Control System01:28

The Cell Cycle Control System

The cell cycle regulation directs how a cell proceeds from one phase to the next and begins mitosis. The cell cycle control system includes intracellular regulatory molecules and external triggers. They provide "stop" or "advance" signals and operate at specific cell cycle stages termed checkpoints to ensure that a particular process is completed before the cell advances to the next phase.
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
5.6K
The Cell Cycle Control System02:11

The Cell Cycle Control System

The cell cycle is an organized set of events that leads the cell to divide into two daughter cells, each containing chromosomes identical to the parent cell. It is the cell cycle that leads to the formation of an entire organism from a single-cell zygote. Besides, cell division also functions in the renewal or repair of tissues in adult multicellular eukaryotes. For example, in the bone marrow, the stem cells divide to form new blood cells. Although essential for several functions, cell...
14.4K